Industry Doctorate Program (CHERE)

Project Member(s): De Abreu Lourenco, R.

Funding or Partner Organisation: NOVARTIS AUSTRALIA PTY LIMITED (Novartis Australia)
NOVARTIS AUSTRALIA PTY LIMITED (Novartis Australia)

Start year: 2020

Summary: Assessing the need for a new framework to evaluate the cost-effectiveness of cell and gene therapies

FOR Codes: Health economics , Health Economics, Health Policy Economic Outcomes, Health Policy Evaluation, Evaluation of health and support services not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.